Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Complications from Xeomin and Daxxify range from mild, expected reactions to rare but serious events requiring immediate medical attention
Eyelid ptosis (drooping) is the most common clinically significant complication and may respond to alpha-adrenergic eye drops in some cases
Serious symptoms like difficulty breathing, swallowing, or generalized weakness require emergency care regardless of location
International patients should establish clear follow-up protocols with their provider before leaving the country
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Potential Complications
Botulinum toxin type A products, including Xeomin (incobotulinumtoxinA) and Daxxify (daxibotulinumtoxinA), have well-established safety profiles derived from extensive clinical use and research. Understanding potential complications helps patients recognize what falls within expected ranges and what warrants clinical evaluation. Both products are FDA-approved and work by temporarily blocking nerve signals to muscles, which creates the desired therapeutic or cosmetic effect but also carries inherent risks that vary among individuals [S1].
The likelihood and severity of complications may depend on several factors: the injector's technique and experience, the specific product used, the treatment area, dosage, and individual patient characteristics such as anatomy and prior exposure to botulinum toxins. Some complications are predictable and self-limiting, while others require prompt clinical intervention [S2].
Common and Expected Reactions
Most patients experience only mild, temporary effects that resolve without intervention. These reactions typically appear within the first few days after treatment and reflect the body's normal response to the injection process itself rather than the toxin's mechanism of action.
Injection site responses are the most frequently reported effects and may include temporary redness, minor bruising, mild pain or tenderness, and slight swelling. These effects usually peak within 24-48 hours and resolve spontaneously within a week. Headaches after treatment are also common and may result from muscle tension or the injection process; most resolve within 24-72 hours and respond to standard over-the-counter analgesics [S2][S3].
Dry mouth and dry eye symptoms occur with some frequency because botulinum toxin can affect nearby glands and tissues. Patients experiencing dry eye may benefit from artificial tears for temporary relief. These symptoms are generally mild and diminish as the toxin effect naturally wears off over weeks to months [S2].
Recognizing Botulinum-Specific Complications
Certain complications arise from the pharmacological action of botulinum toxin spreading beyond the intended treatment area or affecting nearby structures. Recognizing these patterns helps differentiate expected reactions from complications requiring clinical attention.
Eyelid ptosis (drooping of the upper eyelid) is the most clinically significant cosmetic complication and occurs when toxin affects the levator palpebrae muscle. This complication has been reported in clinical literature and may develop 2-10 days after injection [S1]. Ptosis severity varies, and while some cases resolve as the toxin effect diminishes, others may benefit from clinical intervention. Alpha-adrenergic eye drops such as apraclonidine have been used in some cases to temporarily improve eyelid position by stimulating the Mueller muscle [S1]. The incidence of ptosis appears relatively low in large clinical trials but remains the complication patients most frequently report after cosmetic use.
Diplopia (double vision) can occur when toxin affects eye muscles responsible for coordination. This complication requires ophthalmological evaluation and may indicate that the toxin has spread to extraocular muscles. Patients experiencing new or worsening double vision should seek prompt clinical assessment [S1][S2].
Brow position changes and asymmetry may occur when the frontalis muscle is inadvertently affected or when the balance of muscle activity is altered. These effects are usually temporary but may affect appearance until resolution occurs.
Rare but Serious Reactions
While uncommon, certain reactions require immediate medical attention and represent medical emergencies. Patients should understand these risks and know when to seek urgent care.
Dysphagia (difficulty swallowing) may indicate that toxin has spread to pharyngeal or esophageal muscles. This complication occurs more frequently with higher doses or treatments targeting the lower face and neck. Severe or progressive dysphagia warrants immediate medical evaluation [S1][S2].
Respiratory compromise, including difficulty breathing, is a rare but serious complication that may result from toxin affecting respiratory muscles. This requires emergency medical care without delay.
Generalized muscle weakness beyond the treatment area may indicate broader systemic spread of the toxin and should prompt immediate medical consultation.
Allergic reactions and hypersensitivity, while uncommon, have been documented. These may range from local skin reactions to more systemic manifestations. Patients with known allergies to botulinum toxin products or any components should not receive treatment [S2].
Response Protocols by Severity
Appropriate response to complications depends on accurate assessment of severity. This helps determine whether self-monitoring is appropriate, whether routine follow-up is needed, or whether emergency care is required.
Self-Monitoring After Treatment
Patients should monitor their response systematically during the days and weeks following treatment. Understanding the expected timeline aids in distinguishing normal progression from complications requiring intervention.
Initial effects typically begin within 24-72 hours, with full effect developing over 1-2 weeks. Common side effects like bruising and headache usually peak early and improve within the first week. The therapeutic effect gradually diminishes over 3-6 months depending on the product and individual factors [S2][S3].
Documentation through photographs can help track subtle changes over time. Taking baseline photos before treatment and periodic images afterward provides objective reference for assessing any changes.
Signs of allergic reaction such as hives, itching, or swelling beyond the injection site
Clinical Interventions for Moderate Complications
When complications exceed the scope of self-management, clinical interventions may help reduce severity or accelerate recovery. Treatment decisions should be made by qualified healthcare providers familiar with the individual case.
For eyelid ptosis, alpha-adrenergic eye drops (such as apraclonidine 0.5% or brimonidine 0.15%) may be considered to temporarily improve eyelid position by activating the Mueller muscle. These drops are typically applied once or twice daily to the affected eye. The effect is temporary, lasting as long as treatment continues, and ptosis will gradually resolve as the botulinum toxin's effect diminishes [S1]. Patients should consult their treating provider about whether this approach is appropriate for their situation.
Some clinicians have reported using carefully placed injections to address asymmetry, though this approach requires significant expertise and evaluation of individual anatomy [S1].
Follow-up timing depends on complication type and severity. Patients should maintain open communication with their treating provider and report any concerning symptoms promptly.
Escalation Criteria and Emergency Protocols
Certain symptoms indicate medical emergencies requiring immediate care. Patients experiencing these symptoms should seek emergency services without waiting for consultation with their original provider.
Emergency symptoms requiring immediate action:
Difficulty breathing or shortness of breath
Difficulty swallowing that interferes with eating or drinking
Generalized muscle weakness affecting mobility or daily activities
Severe headache with neurological symptoms
Vision loss or significant visual disturbance
Signs of anaphylaxis (difficulty breathing, throat swelling, hives)
If you experience these symptoms while traveling internationally, seek emergency medical care at the nearest appropriate facility. Contact emergency services (such as 112 in Turkey) immediately. If possible, inform emergency responders that you recently received botulinum toxin injections and describe your symptoms clearly [S2].
For non-emergency concerns while traveling, telemedicine follow-up with your original provider may offer guidance, but should not replace emergency care when needed. Keep your treatment documentation accessible, including the specific product used, injection sites, and dosage information.
Special Considerations for International Patients
Patients traveling internationally for treatment face unique considerations regarding complication management. Planning ahead significantly improves outcomes should any concerns arise.
For those considering injectables and botulinum toxin treatments abroad, understanding your provider's follow-up protocols is essential. Reviewing the treatment overview before your appointment can help you prepare informed questions about complication management.
Pre-Treatment Planning
Before booking treatment, international patients should establish clear protocols for post-treatment care. Understanding your provider's approach to follow-up and complication management is essential.
Key pre-treatment actions:
Request written documentation of the treatment, including product name, lot number, injection sites, and dosage
Confirm your provider's availability for follow-up questions after you return home
Understand the expected timeline for full effect and potential side effects
Ask about the clinic's protocol for managing complications in international patients
Verify whether your travel insurance covers treatment-related complications
Identify medical facilities at your destination that can provide emergency care if needed
Travel Documentation
Keep your treatment documentation accessible during your entire trip. A photo of the document stored separately from your phone, along with digital copies, ensures access even if belongings are lost.
Managing Complications While Traveling
When complications occur while abroad, patients must balance appropriate medical care with practical considerations including insurance coverage, follow-up logistics, and communication barriers.
For moderate concerns (such as mild ptosis, persistent headache, or injection site issues), contacting your original provider via telemedicine may help determine whether local care is needed or whether the issue can be monitored until you return home. Many providers offer post-treatment follow-up for international patients through secure telehealth platforms.
Qualified providers can help assess whether symptoms require immediate attention or routine follow-up. Accredited facilities at your destination may provide appropriate care for non-emergency complications.
For serious concerns, seek appropriate local medical care immediately. Emergency departments can provide stabilization and initial management. Keep receipts and medical records for any care received abroad, as these may be relevant to subsequent treatment and insurance claims.
Consider whether returning home is feasible and safe for your specific situation. In some cases, arranging early return while under medical guidance may be appropriate, particularly for complications that require ongoing monitoring or intervention from the original treating team. Travel coordination services can assist with logistics if you need to adjust your return plans.
Prevention and Risk Reduction
While not all complications can be prevented, certain factors reduce risk and are within the patient's control to discuss with their provider.
Provider-Level Risk Mitigation
Injection technique significantly influences complication rates. Patients should feel comfortable discussing their provider's experience and approach before treatment.
Technique factors that may reduce complications:
Accurate anatomical identification of injection sites
Appropriate dosing based on treatment area and individual factors
Proper dilution and reconstitution of the product
Injection depth appropriate to the target muscle
Awareness of anatomical variations among patients
Conservative dosing for first-time treatments or when switching products [S1]
Choosing a provider with appropriate training and experience in botulinum toxin injections—particularly with the specific product being used—represents an important risk reduction strategy. Board certification, documented training, and before-and-after portfolios may help assess provider experience.
Patient Self-Care After Treatment
Following post-treatment instructions helps minimize complications. While specific recommendations vary by provider and product, general guidelines apply broadly.
Recommended post-treatment precautions:
Avoid touching or rubbing the treatment area for at least 24 hours
Remain upright for 4-6 hours after treatment
Avoid strenuous exercise for 24-48 hours
Limit alcohol consumption for 24 hours after treatment
Avoid facials, massages, or other skin treatments for 1-2 weeks
Report any concerning symptoms promptly rather than waiting for scheduled follow-up
Understanding that complications can develop days after treatment—even after initial resolution of common side effects—helps patients maintain appropriate vigilance throughout the entire treatment period [S1].
The clinical trial data for Daxxify (SAKURA 1 and 2 studies) demonstrated its safety and efficacy profile, with adverse events consistent with other botulinum toxin type A products [S4]. Your treating provider can discuss how this data applies to your individual situation.
If you are considering botulinum toxin treatment and want support understanding your options or coordinating with qualified providers, we can help you plan your next steps.
Emergency Notice
If you are experiencing difficulty breathing, severe muscle weakness, or signs of an allergic reaction, seek emergency medical care immediately regardless of your location or travel plans.
4.Carruthers JD, et al.. “SAKURA 1 and SAKURA 2 Investigator Group. DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines.” Plastic and Reconstructive Surgery. 2020. Accessed 2026-02-20.https://pmc.ncbi.nlm.nih.gov/articles/PMC6940025/
External links are provided for educational reference. Verify guidance with qualified clinicians and primary sources where appropriate.
